Literature DB >> 23157240

Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.

Shivaputra A Patil1, Renukadevi Patil, Duane D Miller.   

Abstract

Agents that interfere with tubulin function have a broad anti-tumor spectrum and they represent one of the most significant classes of anticancer agents. In the past few years, several small synthetic molecules that have an indole nucleus as a core structure have been identified as tubulin inhibitors. Among these, several aroylindoles, arylthioindoles, diarylindoles and indolylglyoxyamides have shown good inhibition towards the tubulin polymerization. This article reviews the synthesis, biological activities and SARs of these main classes of indoles. Brief mention has also been made about the fused indole analogs as tubulin inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157240     DOI: 10.4155/fmc.12.141

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  14 in total

1.  Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006).

Authors:  Matthew T Macdonough; Tracy E Strecker; Ernest Hamel; John J Hall; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2013-07-23       Impact factor: 3.641

2.  Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.

Authors:  Mallinath B Hadimani; Matthew T Macdonough; Anjan Ghatak; Tracy E Strecker; Ramona Lopez; Madhavi Sriram; Benson L Nguyen; John J Hall; Raymond J Kessler; Anupama R Shirali; Li Liu; Charles M Garner; George R Pettit; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2013-09-09       Impact factor: 4.050

Review 3.  Synthesis of indole derivatives as prevalent moieties present in selected alkaloids.

Authors:  Majid M Heravi; Zahra Amiri; Kosar Kafshdarzadeh; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2021-10-15       Impact factor: 4.036

4.  Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.

Authors:  Rajendra P Tanpure; Clinton S George; Tracy E Strecker; Laxman Devkota; Justin K Tidmore; Chen-Ming Lin; Christine A Herdman; Matthew T Macdonough; Madhavi Sriram; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2013-09-04       Impact factor: 3.641

5.  IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma.

Authors:  Véronique Martel-Frachet; Michelle Keramidas; Alessandra Nurisso; Salvatore DeBonis; Claire Rome; Jean-Luc Coll; Ahcène Boumendjel; Dimitrios A Skoufias; Xavier Ronot
Journal:  Oncotarget       Date:  2015-06-10

6.  Crystal structure of 6,7-dimeth-oxy-1-(4-nitro-phen-yl)quinolin-4(1H)-one: a mol-ecular scaffold for potential tubulin polymerization inhibitors.

Authors:  Vegard Torp Lien; Dag Erlend Olberg; Jo Klaveness; Carl Henrik Görbitz
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-02-24

7.  A novel Pd-catalysed sequential carbonylation/cyclization approach toward bis-N-heterocycles: rationalization by electronic structure calculations.

Authors:  Liliana Damas; Rui M B Carrilho; Sandra C C Nunes; Alberto A C C Pais; László Kollár; Marta Pineiro; Mariette M Pereira
Journal:  R Soc Open Sci       Date:  2018-09-12       Impact factor: 2.963

Review 8.  A review on recent developments of indole-containing antiviral agents.

Authors:  Ming-Zhi Zhang; Qiong Chen; Guang-Fu Yang
Journal:  Eur J Med Chem       Date:  2014-10-23       Impact factor: 6.514

Review 9.  Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.

Authors:  Dimitris Matiadis; Marina Sagnou
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 10.  Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review.

Authors:  Eavan C McLoughlin; Niamh M O'Boyle
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.